PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
| Autor: | Puhr, Martin, Hoefer, Julia, Neuwirt, Hannes, Eder, Iris E., Kern, Johann, Schäfer, Georg, Geley, Stephan, Heidegger, Isabel, Klocker, Helmut, Culig, Zoran |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Male
chemotherapy resistance Cell Survival Blotting Western Fluorescent Antibody Technique Antineoplastic Agents Apoptosis PIAS1 Docetaxel urologic and male genital diseases Transfection Mice Cell Line Tumor Animals Humans RNA Small Interfering Mice Inbred BALB C Reverse Transcriptase Polymerase Chain Reaction Prostatic Neoplasms prostate cancer Immunohistochemistry Protein Inhibitors of Activated STAT Drug Resistance Neoplasm Tissue Array Analysis Small Ubiquitin-Related Modifier Proteins Heterografts Taxoids Research Paper |
| Zdroj: | Oncotarget |
| ISSN: | 1949-2553 |
| Popis: | Occurrence of an inherent or acquired resistance to the chemotherapeutic drug docetaxel is a major burden for patients suffering from different kinds of malignancies, including castration resistant prostate cancer (PCa). In the present study we address the question whether PIAS1 targeting can be used to establish a basis for improved PCa treatment. The expression status and functional relevance of PIAS1 was evaluated in primary tumors, in metastatic lesions, in tissue of patients after docetaxel chemotherapy, and in docetaxel resistant cells. Patient data were complemented by functional studies on PIAS1 knockdown in vitro as well as in chicken chorioallantoic membrane and mouse xenograft in vivo models. PIAS1 was found to be overexpressed in local and metastatic PCa and its expression was further elevated in tumors after docetaxel treatment as well as in docetaxel resistant cells. Furthermore, PIAS1 knockdown experiments revealed an increased expression of tumor suppressor p21 and declined expression of anti-apoptotic protein Mcl1, which caused diminished cell proliferation and tumor growth in vitro and in vivo. In summary, the presented data indicate that PIAS1 is crucial for parental and docetaxel resistant PCa cell survival and is therefore a promising new target for treatment of primary, metastatic, and chemotherapy resistant PCa. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|